Copper Storage Hepatopathy

TL;DR. Copper storage hepatopathy is a metabolic disorder where toxic levels of copper accumulate in the liver, causing chronic inflammation and damage that can lead to liver failure if left untreated.

The Bedlington Terrier is the most well-documented breed affected by inherited copper storage hepatopathy.

What is it?

Copper storage hepatopathy, also known as copper storage disease or copper-associated chronic hepatitis, is a metabolic disorder characterized by the abnormal and excessive accumulation of copper within the cells of the liver (hepatocytes). Copper is an essential trace mineral that pets ingest through their diet. Under normal physiological conditions, the liver processes this copper and excretes any excess safely through bile, which is then eliminated in the feces. However, when this excretion pathway is disrupted—either due to an inherited genetic defect or secondary to another liver disease—copper levels build up to toxic proportions.

As copper levels rise within the liver cells, the mineral begins to cause severe oxidative damage. This cellular stress triggers a cascade of chronic inflammation, known as chronic hepatitis. Over time, the ongoing destruction of liver cells leads to the formation of scar tissue, a process called fibrosis. If left unchecked, this scarring can progress to cirrhosis, which is irreversible liver failure. In rare and severe cases, the sudden release of copper or rapid cellular collapse can cause acute fulminant hepatic necrosis, a catastrophic and often fatal event where large portions of the liver die suddenly.

While this condition is primarily recognized and studied in dogs, cats can also be affected. It is important to note that copper storage hepatopathy is considered uncommon in the feline population. Because of its rarity in cats, much of the veterinary guidance, diagnostic interpretation, and treatment protocols for felines are extrapolated from canine medicine and human metabolic research. Regardless of the species, early intervention is critical to stopping the progressive damage before the liver loses its ability to function.

The liver is responsible for processing copper and excreting excess amounts through bile.

Causes & risk factors

The causes of copper storage hepatopathy are generally divided into two categories: primary and secondary. Primary copper storage hepatopathy is an inherited genetic disorder. In these cases, the animal is born with a metabolic defect that prevents the liver from properly transporting or excreting copper. The most clearly defined genetic defect occurs in the Bedlington Terrier, where a mutation in the COMMD1 gene leads to a failure in copper excretion.

Secondary copper storage hepatopathy occurs when an underlying liver disease blocks the normal flow of bile (cholestasis). Because copper is primarily excreted through bile, any disease that causes bile duct obstruction or chronic inflammation can lead to a secondary backup of copper in the liver tissue.

Several dog breeds have a known or highly suspected genetic predisposition to this condition:

• Bedlington Terrier: Highly predisposed; inherited as an autosomal recessive trait.
• Labrador Retriever: Suspected genetic predisposition; highly documented.
• Doberman Pinscher: Suspected genetic predisposition; often presents with a long subclinical phase.
• Dalmatian: Suspected genetic predisposition.
• West Highland White Terrier: Suspected genetic predisposition.
• Skye Terrier: Suspected genetic predisposition.

According to a leading veterinary internal medicine textbook:

"True copper storage disease likely represents a genetic defect in copper transport and/or storage, but the only breed in which this has been defined is the Bedlington Terrier. In this breed it is inherited as an autosomal recessive trait, and up to 60% of Bedlington Terriers in some countries have been affected in the past, although the prevalence is now decreasing as a result of selective breeding."

Signs to watch for

One of the most challenging aspects of copper storage hepatopathy is its silent progression. Many dogs and cats live with the disease for years without showing any outward signs of illness. During this subclinical phase, copper is slowly accumulating and damaging the liver. When clinical signs finally appear, they are often non-specific and mimic other gastrointestinal or metabolic illnesses.

Common Signs

• Vomiting: Frequent or intermittent bouts of vomiting as liver function declines.
• Anorexia: A persistent loss of appetite or reluctance to eat.
• Lethargy: General weakness, low energy, and a lack of interest in normal activities.
• Persistently high ALT activity: Alanine aminotransferase (ALT) is a liver enzyme. While not an outward sign you can see at home, persistently elevated ALT levels on routine blood chemistry panels are a primary indicator of active liver cell damage.

Occasional Signs

• Cirrhosis: Advanced scarring of the liver, which can lead to fluid accumulation in the abdomen (ascites).
• Polyuria and polydipsia (PU/PD): Increased drinking and urination, which occurs as the liver loses its ability to process waste products, affecting kidney concentration mechanisms.
• Acute intravascular hemolytic anemia: A condition where red blood cells are rapidly destroyed within the bloodstream. This can happen if a sudden release of copper from damaged liver cells floods the blood, causing toxic damage to red blood cell membranes.

Rare Signs

• Acute fulminant hepatic necrosis: A sudden, massive failure of the liver cells, leading to rapid onset of severe illness, jaundice (yellowing of the eyes, gums, and skin), hepatic encephalopathy (neurological signs like head pressing or seizures), and death.

Lethargy and loss of appetite are common, non-specific signs of progressive liver damage.

How vets diagnose it

Diagnosing copper storage hepatopathy requires a systematic veterinary workup. Because the early stages of the disease are silent, your vet may first suspect an issue after finding elevated liver enzymes—specifically ALT—on routine wellness blood tests. However, bloodwork alone cannot confirm copper storage disease, as many different liver conditions can cause elevated enzymes.

If your dog is a Bedlington Terrier, your vet may recommend COMMD1 genetic testing. This simple DNA test can identify if the dog carries the mutated gene responsible for the disease. For other breeds and cats, genetic testing is not yet widely available or fully defined, making other diagnostic steps necessary.

The gold standard for diagnosing copper storage hepatopathy is a liver biopsy. This procedure is performed under general anesthesia, typically using laparoscopy or ultrasound guidance to obtain small tissue samples from the liver. A biopsy is essential because it allows a veterinary pathologist to visually evaluate the liver tissue, determine the severity of inflammation and scarring, and perform specific diagnostic tests on the tissue itself.

During the biopsy evaluation, the pathologist will perform quantitative measurement of copper content. This is a highly precise test that measures the actual concentration of copper in micrograms per gram of dry liver tissue. Additionally, they will use special chemical stains, such as Rhodanine or rubeanic acid staining, to visualize exactly where the copper is accumulating within the liver cells.

As noted in a prominent veterinary critical care reference:

"Hepatic tissue should be harbored for copper quantification in any dog undergoing liver biopsy."

Special stains like rhodanine allow pathologists to visualize copper deposits directly within liver cells.

Treatment options

Treatment for copper storage hepatopathy is tailored to the stage of the disease and whether the animal is showing active symptoms. The primary goals of therapy are to remove excess copper from the body, prevent further copper accumulation, and protect the liver from ongoing oxidative damage.

First-Line Chelating Agents (Antidotes)

Chelating agents are medications that bind to copper in the bloodstream and tissues, forming a soluble compound that the kidneys can safely filter and excrete in the urine.

• Penicillamine: This is the most commonly used first-line chelating agent. It is highly effective at gradually reducing liver copper levels over several months. However, it is not designed for rapid action in acute medical crises.
• Trientine: This is another potent chelating agent used as an alternative first-line therapy, particularly in dogs that cannot tolerate penicillamine or require alternative chelation pathways.

According to a leading veterinary internal medicine reference:

"Penicillamine is not helpful in an acute crisis because chelation takes weeks to months. However, it should be noted that there is much less information available about the pharmacokinetics, drug interactions, and toxicity of trientine in dogs than there is for d-penicillamine. Reported adverse effects include nausea, gastritis, abdominal pain, melena, and weakness."

Supportive & Hepatoprotective Therapies

In addition to removing copper, your vet will prescribe medications to support liver health and reduce inflammation:

• Ursodiol: This is a synthetic bile acid that acts as a hepatoprotectant. It helps thin the bile, promoting its flow and reducing the toxic effects of retained bile acids on liver cells. It also has mild anti-inflammatory properties.
• Vitamin A: This nutritional supplement and retinoid may be discussed as part of a broader antioxidant regimen, though it must be used with extreme caution. Because the liver stores Vitamin A, excessive supplementation can lead to toxicity, so it should only be administered under strict veterinary supervision.
• Dietary Management: Transitioning your pet to a prescription liver diet that is strictly formulated to be low in copper and high in zinc is a cornerstone of long-term management. Zinc competes with copper for absorption in the intestines, helping to limit further copper uptake.

Prognosis

The prognosis for pets with copper storage hepatopathy varies dramatically depending on when the disease is diagnosed and how far it has progressed.

For dogs and cats diagnosed during the asymptomatic or subclinical phase—before significant inflammation or scarring has occurred—the prognosis is excellent to slowly progressive. With lifelong dietary management, copper chelators, and routine monitoring, these animals can live normal, high-quality lives.

Conversely, the prognosis is poor once hepatic failure, advanced cirrhosis, or acute fulminant hepatic necrosis develops. In these advanced stages, the liver has lost its ability to regenerate, and medical management is focused on palliative care to maintain comfort. As detailed in veterinary literature:

"The prognosis is poor, and most animals die within a few days [in acute crises]. Fortunately, this is uncommon; most dogs have a more chronic, protracted course, with several years of copper buildup and persistently high ALT activity, culminating in the development of chronic hepatitis with piecemeal necrosis, inflammation, and bridging fibrosis."

Prevention

For breeds with a known genetic predisposition, prevention centers on proactive screening and responsible breeding practices.

• Genetic Screening: Bedlington Terriers should undergo COMMD1 genetic testing before breeding to prevent passing the autosomal recessive trait to offspring.
• Routine Blood Monitoring: For other predisposed breeds, such as Labrador Retrievers and Doberman Pinschers, routine annual bloodwork starting at a young age is highly recommended. Monitoring ALT levels allows vets to catch the disease in its silent, subclinical phase.
• Dietary Prevention: If you own a highly predisposed breed, discuss preventative dietary options with your vet. Avoiding high-copper foods (such as organ meats, shellfish, and legumes) and testing your home's tap water for high copper levels can help limit early exposure.

When to call your vet

If your pet belongs to a predisposed breed, you should establish a routine monitoring plan with your veterinarian. You should contact your vet if you notice subtle, ongoing signs of illness such as occasional vomiting, a gradual decrease in appetite, or unexplained lethargy.

You must seek emergency veterinary care immediately if your pet exhibits signs of acute liver crisis, including sudden and severe vomiting, yellowing of the gums, eyes, or skin (jaundice), extreme weakness, dark tarry stools (melena), or sudden neurological changes such as disorientation or head pressing.

For specific breeds

Different breeds experience copper storage hepatopathy in distinct ways, making breed-specific awareness vital for owners:

• Bedlington Terriers: Because the disease is inherited as an autosomal recessive trait, genetic testing is the most powerful tool available. Responsible breeding has significantly reduced the prevalence of this disease in recent decades.
• Doberman Pinschers: These dogs often experience a very long subclinical phase. They may appear completely healthy while copper silently builds up, only to experience a sudden, severe